Analysts Set Aspen Aerogels, Inc. (NYSE:ASPN) Target Price at $19.11

Shares of Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) have received an average rating of "Buy" from the ten analysts that are presently covering the company, Marketbeat reports. One research analyst has rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $19.11.

A number of brokerages have recently issued reports on ASPN. TD Cowen upgraded shares of Aspen Aerogels to a "strong-buy" rating in a research report on Tuesday, March 11th. Roth Mkm decreased their price objective on Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating on the stock in a research report on Friday, February 14th. StockNews.com upgraded Aspen Aerogels to a "sell" rating in a research report on Wednesday, February 19th. B. Riley cut their target price on shares of Aspen Aerogels from $35.00 to $22.00 and set a "buy" rating on the stock in a research report on Wednesday, February 19th. Finally, Barclays lowered their target price on shares of Aspen Aerogels from $25.00 to $13.00 and set an "overweight" rating for the company in a report on Wednesday, February 19th.

Aspen Aerogels Stock Performance

ASPN traded down $0.44 on Friday, hitting $5.08. 599,952 shares of the stock traded hands, compared to its average volume of 1,878,201. The business has a fifty day moving average price of $7.85 and a two-hundred day moving average price of $13.40. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The firm has a market capitalization of $416.68 million, a PE ratio of 31.79 and a beta of 2.35. Aspen Aerogels has a 52 week low of $4.80 and a 52 week high of $33.15.

Remove Ads

Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. On average, research analysts predict that Aspen Aerogels will post 0.17 EPS for the current fiscal year.

Institutional Investors Weigh In On Aspen Aerogels

Hedge funds have recently modified their holdings of the company. Sanders Morris Harris LLC boosted its holdings in shares of Aspen Aerogels by 14.3% during the 1st quarter. Sanders Morris Harris LLC now owns 40,000 shares of the construction company's stock worth $256,000 after buying an additional 5,000 shares in the last quarter. GAMMA Investing LLC lifted its position in shares of Aspen Aerogels by 1,998.7% during the first quarter. GAMMA Investing LLC now owns 3,316 shares of the construction company's stock worth $210,000 after acquiring an additional 3,158 shares in the last quarter. Penbrook Management LLC bought a new stake in Aspen Aerogels during the first quarter valued at $116,000. Wealth Enhancement Advisory Services LLC purchased a new stake in Aspen Aerogels during the fourth quarter valued at about $129,000. Finally, Palogic Value Management L.P. bought a new stake in shares of Aspen Aerogels in the 4th quarter worth approximately $1,544,000. Institutional investors and hedge funds own 97.64% of the company's stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.